ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
A Holistic Approach to Transforming Clinical Trials
PharmaVOICE presents a podcast featuring ICON expert Marie McCarthy & Chen Admati (Intel), discussing the use of emerging tech to improve the efficiency of R&D.
Patient Engagement Web Platform from ICON Bolsters Clinical Connectivity
An Outsourcing Pharma article featuring commentary from EB McLindon & Gretchen Goller, on ICON’s new web-based patient engagement platform.
US Healthcare Reform Scenarios
There has been growing interest among politicians & the public for significant change of the US healthcare system.
ICON Introduces New Platform for Potential Trial Participants
A Clinical Trials Arena article on ICON's new patient engagement platform, supporting people interested in participating in clinical trials.
A New Horizon
A PharmaTimes article featuring commentary from Tom O’Leary on the future of AI in healthcare.
Adopting mHealth Technologies in CV Trials
A Pharmafile article authored by Marie McCarthy and Jack Martin on the use of mHealth technologies in cardiovascular trials.
Rare Disease Trials Q&A
A PME article discussing the challenges of rare disease trials, including those of recruitment and retention unique to rare disease studies.
The Need for New Business Models under MDR/IVDR
A thought leadership article on the approaching deadline for the new medical devices regulation (MDR) & in vitro diagnostic device regulation (IVDR).
ICER's Growing Impact On Drug Pricing And Reimbursement
Read Forbes' article featuring ICON research insights exploring how ICER may have a greater impact on payer decision-making than expected.
The Rise of Patient-Centricity
In the April 2019 issue of PME, ICON's Matt McCarty discusses the importance of understanding what patients value and ways to gather patient insights.